pantoprazole has been researched along with Bile Reflux in 3 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Bile Reflux: Retrograde bile flow. Reflux of bile can be from the duodenum to the stomach (DUODENOGASTRIC REFLUX); to the esophagus (GASTROESOPHAGEAL REFLUX); or to the PANCREAS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether pantoprazole also reduces bile reflux and whether this is paralleled by a change in oesophageal motility." | 9.09 | Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. ( Brundler, R; Gaia, C; Gut, A; Halter, F; Inauen, W; Netzer, P, 2001) |
| "To investigate whether pantoprazole also reduces bile reflux and whether this is paralleled by a change in oesophageal motility." | 5.09 | Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. ( Brundler, R; Gaia, C; Gut, A; Halter, F; Inauen, W; Netzer, P, 2001) |
| "Treatment with pantoprazole resulted in a significant reduction of acidic reflux in both PPI responders and PPI nonresponders." | 1.38 | Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy. ( Ellenrieder, V; Gress, TM; Kunsch, S; Linhart, T; Neesse, A; Nell, C, 2012) |
| "Both acid and bile reflux is significantly suppressed by proton pump inhibitor therapy with exceptions among individual esophagitis patients." | 1.31 | Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. ( Menges, M; Müller, M; Zeitz, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunsch, S | 1 |
| Neesse, A | 1 |
| Linhart, T | 1 |
| Nell, C | 1 |
| Gress, TM | 1 |
| Ellenrieder, V | 1 |
| Menges, M | 1 |
| Müller, M | 1 |
| Zeitz, M | 1 |
| Netzer, P | 1 |
| Gut, A | 1 |
| Brundler, R | 1 |
| Gaia, C | 1 |
| Halter, F | 1 |
| Inauen, W | 1 |
1 trial available for pantoprazole and Bile Reflux
| Article | Year |
|---|---|
Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2001 |
2 other studies available for pantoprazole and Bile Reflux
| Article | Year |
|---|---|
Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Bile Reflux; Drug Resistance; Esophageal pH Monitori | 2012 |
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Bile Reflux; Case-Contro | 2001 |